Proposed clinical algorithm for hematinic bhasmas selection for Ayurvedic pediatric care Authors: K.P. Karthik, Arun Kumar Mahapatra, Prashant Kumar Gupta, S. Rajagopala Published: 2024 ABSTRACT Ayurveda has unique and relevant methods in nosology, symptomatology, and drug selection. These methods need a novel and effective way of presentation for convenient comprehension and implementation. ‘Clinical algorithms’ is one such way, wherein a large amount of data is simplified, conceptual intricacies abstracted, and clinical application made easier. This article uses a modified version of the Horabin and Lewis algorithm to construct a clinical algorithm for Bhasma selection in the management of Pandu (anemia). The textual descriptions regarding the pathology and clinical presentations of Pandu have been compiled, and broadly classified, and the Bhasmas indication in suit each set of disease presentation has been specified. The algorithm is validated and optimized at single centre, while multicentre implementations and post-hoc modifications are warranted. Introduction Most ancient texts of Ayurveda, like the greater triad (Brihattrayis) had variety and stage-based disease description and management and the pedagogy of the period was probably oriented towards decoding this ‘order’. As time progressed, formulation-based texts replaced the then mainstream concepts and diagnosis pattern, further curriculum-based study replaced the text-based study and eventually, these geographically diverse concepts were either diluted or near-undecipherable. The overall scenario pushes for a novel method of representation of diagnosis and management of various disorders. Clinical algorithms are described as “organized sequences of procedures for decision-making regarding the diagnosis and management of a symptom or disease in order to improve the healthcare delivery”. Algorithms can simplify larger data, and abstract the conceptual intricacies, making it clinically advantageous [1]. Anemia has a wide, variegated clinical presentation managed on outpatient basis. Ayurveda has an in-depth description of symptoms and etiology-based treatment of Anemia (Pandu). Authors have attempted a clinical algorithm based on the ‘Horabin-Lewis method for algorithms’, modified for medical settings [2]. (Fig. 1) for Pandu management through classical Bhasma formulations.Fig. 1Modified Horabin and Lewis algorithm and its adaptation to the current study.Fig. 1 Modified Horabin and Lewis algorithm and its adaptation to the current study. Step 1: Setting definition Anemia has high global prevalence among pre-school (47.4%) and school-going children (25.4%) [3] and touches every socio-economic stratum in India. Multiple marathon national programs running in India have a primary objective of Anemia elimination and are still lagging in achieving the targets [4]. Conventional anemia treatment includes oral medication and food and lifestyle corrections. Such oral medication like iron supplementation has varied side effects and an alternative solution may be appreciated. In Ayurveda, Pandu has clinically same presentation as Anemia, and its management basket has mostly iron/iron oxide formulation [5]. Overemphasizing iron/iron oxide in anemia management, undermines several other minerals that can manage “anemia-linked” symptoms. So, a comprehensive, clinician-friendly database can portray signs/symptoms, and management of anemia better. Child-centric management further requires safety, palatability, and lower doses. Step 2: Evaluation of current knowledge Anemia and hematinics: Ayurveda approach Ayurveda uses the umbrella term “Pandu” covering a spectrum of symptoms including pallor. Though they express similar manifestations, the pathological foci are different. Iron containing herbo-mineral preparations constitute a fair share in Pandu therapies. In Western biomedicine, dietary and other external factors are well-explored in terms of iron supplements, and diet promoting or hampering iron absorption, etc. whereas the host (internal) factors regulating iron absorption have been insufficiently weighted [6]. Ayurveda has diagnostic and therapeutic focus towards internal factors like psychosomatic constitution (Prakriti), the strength of the pathology (Vikriti), Doshas-Dushya interaction, and their reversal (Sampraptivighatana) which accounts to the position of bio-purificatory (Shodhana), food and lifestyle modifications as the first line treatment strategy of Pandu. (Ca. Ci. 16/40) Iron-containing formulations and other hematinics are recommended in the pacification (Shamana) and rejuvenation (Rasayana) phases, which are either preceded by purification therapies or done independently. Bhasma: A pediatric-friendly dosage form Besides their therapeutic properties like ability to maintain an optimum, alkaline environment, Bhasmas (processed, calcined metals or minerals) are usually tasteless and orally well tolerated. Lower therapeutic doses also make their administration convenient in children. Svarna Bhasma has been extensively advocated in pediatric population. Moreover, they also help the metabolization of iron in body [7]. Parada (Hg) and Louha (Fe) Bhasma have been used both independently and as a part of compound formulations in bronchial asthma and iron deficiency anemia respectively [8]. Kasisa bhasma (FeSO4.7H2O) ameliorated serum hemoglobin at levels comparable to that of oral iron therapy in IDA [9]. Swarnamakshika (CuFeS2) bhasma has also been found significantly improves hemoglobin levels in rats [10]. Rajata (Ag)and Vanga (Sn) bhasma also evinced hematinic benefits [11,12]. Step 3: Decision strategy A strategy was devised for decision strategy as depicted in Fig. 1. Step 4: Decision criteria Bipolarity of Pandu Vitiation and attrition of Rasa (Ca. Su. 28/4) and Rakta (Su. Su. 14/21) manifest Pandu. So Pandu was broadly classified into vitiation-predominant (Dushtipradhana) and deficit-predominant (Kshayapradhana) that are most likely to be Kapha-Pitta and Vata-Pitta predominant in nature respectively. This Bipolar approach can ease diagnostic and therapeutic baseline decisions. Pandu has been explained in Ayurvedic classics to originate and traverse through multiple pathogenetic pathways. The mostly endorsed one involves the disturbance of Kapha, Vata, Rakta, Tvak, and Mamsa, which is triggered by the aggravation of Pitta due to external factors, as referenced in Cha. Chi. 16/9–10 [21]. Another mechanism is the vitiation of Rasa dhatu, indicated in Cha. Su. 28/10. Additionally, the involvement of Rakta alone in causing Pandu is documented in Su. U. 40/3. The loss of Rakta represents another critical pathway, cited in Su. Su. 14/30 [22]. The affliction of Rakta by Kapha is also a potential mechanism, as noted in A. Sam. Su. 19/22 [23]. The basic variables Algorithm construction for classical Ayurveda concepts are complex and difficult due to crosstalk (up-regulation, down-regulation, and synergistic regulations) among different external and internal factors (climate, region, age, metabolism). Such factors can trench confounders and make the algorithm complicated [13]. Hence, we considered the baseline variables regarding diagnosis and treatment, i.e., Doshas and Rasas. The Ayurvedic texts were initially searched for Bhasmas that were prescribed for hematinic activity or having Pandu in its indications. Selected Bhasmas were searched on PubMed/MEDLINE, DHARA (Digital Helpline for Ayurveda Research Articles), AFI and Rasaśastra literature for its hematinic activities. The Rasa attribute of the Bhasma and its specific indications in terms of Doṣa and co-existent symptoms were identified. The Rasas were grouped as Madhura-Amla-Lavana and Kashaya-Tikta-Katu for Kshayapradhana and Dushtipradhana variants respectively. Step 5: Creation of algorithm Bhasmas used in the Pandu spectrum Bhasmas (both iron and non-iron based) possess potential hematinic activity documented in texts like Rasatarangini, [14] Ayurveda Sara sangraha [15], Rasatantrasara and Siddhaprayogasangraha [16], Ayurveda oushadhigunadharmashastra [17], Bhaishajyaratnavali [18], and so on. The dosage and synergistic adjuvants of the Bhasma have also been noted. These documentations were compiled and the Bhasmas, indications, adjuvants and dosage were streamlined based on accessibility, feasibility, and safety in the pediatric population. (Fig. 2).Fig. 2Graphical representation of the clinical algorithm.Fig. 2 Graphical representation of the clinical algorithm. Dosage The dosages mentioned in the Ayurvedic Formulary of India (Table 1) [19]are the adult dosages and the paediatric doses were calculated based on Young's rule [20]. Clinical research for Bhasma's paediatric doses is highly warranted.Table 1Dosages of bhasmas as per the ayurvedic formulary of IndiaTable 1BhasmaDosage as per AFIAbhraka Bhasma125 mg–375 mgGodanti Bhasma500 mgKasissa Bhasma250 mgLauha Bhasma120 mg–250 mgMandura Bhasma250 mg–500 mgPravala Bhasma250 mgRajata Bhasma125 mgSvarnamakshika Bhasma120 mg–250 mgTamra Bhasma31.25 mg–62.5 mgYashada Bhasma125 mg Table 1Dosages of bhasmas as per the ayurvedic formulary of IndiaTable 1BhasmaDosage as per AFIAbhraka Bhasma125 mg–375 mgGodanti Bhasma500 mgKasissa Bhasma250 mgLauha Bhasma120 mg–250 mgMandura Bhasma250 mg–500 mgPravala Bhasma250 mgRajata Bhasma125 mgSvarnamakshika Bhasma120 mg–250 mgTamra Bhasma31.25 mg–62.5 mgYashada Bhasma125 mg Dosages of bhasmas as per the ayurvedic formulary of India Step 6 and step 7: Implementation in practice and validation and optimization The algorithm was revised multiple times till graphic acceptability (as stated in Step 6 of the conventional method of Horabin and Lewis) and model viability was attained. It was subjected to multiple peer discussions, wherein SWOT analysis was done, and necessary amendments were made. The limitations that were beyond the scope of improvement in this phase of the algorithm and the utilities were listed. Implementation at multiple Ayurvedic pediatric centres is required for the post hoc feedback and further modifications. Utility Rearrangement of the diagnostic and therapeutic possibilities into algorithms save time, efforts and reduces iatrogenic mistakes. Arrangements are based on the basic variables i.e., Dosha and Rasa, hence, facilitating addition of more candidates of similar properties to the algorithm. Algorithm may be referred from periphery to centre for clinical purpose while academic exploration is from centre to periphery. The drugs and methods mentioned herein may be extrapolated to other diseases with necessary amendments like dose, adjuvants, etc. Such arrangements can ease the process of drug repurposing (Bhasma) in emerging diseases of common pathology. Limitations Svarna Bhasma and Hira Bhasma, though effective in the spectrum, have not been included citing high price and Vaikranta Bhasma have also been omitted due to rare use. Tamra Bhasma should be administered carefully, and dose reverification is advised. Rasas are insufficient to represent the action of every drug, as some drugs acts through Guna, Virya, Vipaka, or Prabhava. Hence, Bhasmas under Vichitrapratyayarabdha or Vikriti-Vishama-samavaya may not fit into proposed algorithm. They may require a separate design. Lauha and Mandura have been placed at the midline for their universal indication in the spectra of Pandu. The authors have not taken part of the next consequential step or recovery step out of this algorithm. The current algorithm is not built on statistical tools, rather classical references are used. ‘Outliers’ of various kinds, as stated above, have been excluded. Conclusion An attempt has been made here to sketch an algorithm for choosing hematinic Bhasmas in children. Despite its limitations, this algorithm provides a better clinical and research understanding of the topic and gives more, precise therapeutic choices. Such algorithms can also be used as templates for developing guidelines for clinical practice and further research as ‘systems biology’ and ‘network pharmacology’. Funding sources The study has not received any grants or funding of any kind from any organization. Conflict of interest None. Declaration of generative AI in scientific writing This review article was prepared without generative artificial intelligence (AI) tools. All content, including literature search, data analysis, and manuscript preparation, was conducted by the authors using traditional scholarly research methods without assistance from AI-based software or algorithms. Author contribution KKP: Managed data collection and analysis, and assisted in drafting the manuscript. AKM: Drafted the manuscript, interpreted data, and contributed intellectual revisions. PKG: Conceptualized and designed the work, and provided intellectual revisions. RGS: Provided final approval for the version to be published and agreed to be accountable for all aspects of the work.-